Cebranopadol, a Mixed Opioid Agonist, Reduces Cocaine Self-administration through Nociceptin Opioid and Mu Opioid Receptors.

MLA

Qianwei Shen, et al. “Cebranopadol, a Mixed Opioid Agonist, Reduces Cocaine Self-Administration through Nociceptin Opioid and Mu Opioid Receptors.” Frontiers in Psychiatry, Nov. 2017, pp. 1–9. EBSCOhost, https://doi.org/10.3389/fpsyt.2017.00234.

APA

Qianwei Shen, Yulin Deng, Ciccocioppo, R., & Nazzareno, C. (2017). Cebranopadol, a Mixed Opioid Agonist, Reduces Cocaine Self-administration through Nociceptin Opioid and Mu Opioid Receptors. Frontiers in Psychiatry, 1–9. https://doi.org/10.3389/fpsyt.2017.00234

Chicago

Qianwei Shen, Yulin Deng, Roberto Ciccocioppo, and Cannella Nazzareno. 2017. “Cebranopadol, a Mixed Opioid Agonist, Reduces Cocaine Self-Administration through Nociceptin Opioid and Mu Opioid Receptors.” Frontiers in Psychiatry, November, 1–9. doi:10.3389/fpsyt.2017.00234.